Not logged in Five-year overall survival in JCOG1205/1206: irinotecan or etoposide plus cisplatin for resected high-grade neuroendocrine carcinoma of the lung Kenmotsu, Hirotsugu; Niho, Seiji; Tsuboi, Masahiro; Wakabayashi, Masashi; Ishii, Genichiro; Asahina, Hajime; Watanabe, Kana; Kiyoshima, Moriyuki; Iwata, Takekazu; Nakamura, Yukiko; Nakahara, Yoshiro; Chen-Yoshikawa, Toyofumi Fengshi; Nishino, Kazumi; Nishio, Wataru; Yokoyama, Toshihide; Mitome, Noriko; Asamura, Hisao; Ohe, Yuichiro; Watanabe, Shun-ichi Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
First-line nivolumab plus platinum chemotherapy and bevacizumab for advanced nonsquamous non-small cell lung cancer: A 3-year follow-up of the phase 3 randomized TASUKI-52 trial Lee, Ki Hyeong; Lee, Jong-Seok; Sugawara, Shunichi; Kang, Jin Hyoung; Kim, Hye Ryun; Inui, Naoki; Hida, Toyoaki; Yoshida, Tatsuya; Tanaka, Hiroshi; Yang, Cheng-Ta; Inoue, Takako; Nishio, Makoto; Ohe, Yuichiro; Tamura, Tomohide; Yamamoto, Nobuyuki; Yu, Chong-Jen; Akamatsu, Hiroaki; Takahashi, Shigeru Share Save
WEE1 confers resistance to KRASG12C inhibitors in non-small cell lung cancer Yamamoto, Gaku; Tanaka, Kosuke; Kamata, Ryo; Saito, Hitoshi; Yamamori-Morita, Tomoko; Nakao, Takehiro; Liu, Jie; Mori, Shunta; Yagishita, Shigehiro; Hamada, Akinobu; Shinno, Yuki; Yoshida, Tatsuya; Horinouchi, Hidehito; Ohe, Yuichiro; Watanabe, Shun-Ichi; Yatabe, Yasushi; Kitai, Hidenori; Konno, Satoshi; Kobayashi, Susumu S.; Ohashi, Akihiro Share Save
Share Save
Second OS interim analysis from BEAT-SC: A randomized phase III study of bevacizumab (bev) or placebo in combination with atezolizumab and platinum-based chemotherapy in patients with extensive-stage small cell lung cancer (ES-SCLC) Han, B.; Ohe, Y.; Nishio, M.; Watanabe, S.; Ren, X.; Murakami, S.; Yang, N.; Okamoto, I.; Li, G.; Katakami, N.; Liu, X.; Hamaguchi, N.; Nakagawa, Y.; Hayashi, M.; Nanki, T.; Qian, C.; Yamamoto, N. Share Save
A phase III study comparing weekly carboplatin plus nabpaclitaxel and daily low-dose carboplatin for concurrent chemoradiotherapy in elderly patients (≥75 years) with unresectable locally advanced NSCLC: JCOG1914 Omori, S.; Kenmotsu, H.; Takahashi, T.; Nomura, S.; Harada, H.; Ishikura, S.; Ando, M.; Izumi, H.; Shinno, Y.; Oki, M.; Masuda, T.; Yokoyama, T.; Hosomi, Y.; Shimokawa, T.; Murakami, S.; Kurosaki, T.; Yoshioka, H.; Mitome, N.; Fukuda, H.; Ohe, Y. Share Save
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older Yagishita, Shigehiro; Yamanaka, Yuta; Kurata, Takayasu; Watanabe, Kageaki; Hosomi, Yukio; Horinouchi, Hidehito; Ohe, Yuichiro; Nakahara, Yoshiro; Naoki, Katsuhiko; Asao, Tetsuhiko; Takahashi, Kazuhisa; Saeki, Sho; Sakagami, Takuro; Nakashima, Kazuhisa; Tsubata, Yukari; Fujita, Yu; Wakui, Hiroshi; Furuta, Megumi; Konishi, Jun Sakakibara; Ohuchi, Mayu; Ando, Yuichi; Mizugaki, Hidenori; Hamada, Akinobu Share Save
Mechanism of ERBB2 gene overexpression by the formation of super-enhancer with genomic structural abnormalities in lung adenocarcinoma without clinically actionable genetic alterations Kaneko, Syuzo; Takasawa, Ken; Asada, Ken; Shiraishi, Kouya; Ikawa, Noriko; Machino, Hidenori; Shinkai, Norio; Matsuda, Maiko; Masuda, Mari; Adachi, Shungo; Takahashi, Satoshi; Kobayashi, Kazuma; Kouno, Nobuji; Bolatkan, Amina; Komatsu, Masaaki; Yamada, Masayoshi; Miyake, Mototaka; Watanabe, Hirokazu; Tateishi, Akiko; Mizuno, Takaaki; Okubo, Yu; Mukai, Masami; Yoshida, Tatsuya; Yoshida, Yukihiro; Horinouchi, Hidehito; Watanabe, Shun-Ichi; Ohe, Yuichiro; Yatabe, Yasushi; Saloura, Vassiliki; Kohno, Takashi; Hamamoto, Ryuji Share Save
Share Save
Amivantamab in wild-type advanced non-small cell lung cancer after disease progression on checkpoint inhibition and chemotherapy: Results from the phase 1b CHRYSALIS study Cho, Byoung Chul; Goldman, Jonathan; Leighl, Natasha; De Braud, Filippo; Lee, Ki Hyeong; Ghiringhelli, Francois; Garrido, Pilar; Peguero, Julio; Besse, Benjamin; Cassier, Philippe; Girard, Nicolas; de Miguel, Maria; Alvarez, Rosa; Greystroke, Alastair; Ohe, Yuichiro; Hsia, Te-Chun; Curtin, Joshua C.; Chowdhury, Sanjib; Lyu, Xuesong; Gao, Grace; Qu, Siyang; Lorenzini, Patricia; Kapoor, Aastha; Kim, Priya; Baig, Mahadi; Thayu, Meena; Knoblauch, Roland E.; Hiret, Sandrine; Tomasini, Pascale Share Save
Association between skin toxicity and ef fi cacy of necitumumab in squamous non-small-cell lung cancer: a pooled analysis of two randomized clinical trials-SQUIRE and JFCM Watanabe, S.; Yoshioka, H.; Sakai, H.; Hotta, K.; Takenoyama, M.; Yamada, K.; Sugawara, S.; Takiguchi, Y.; Hosomi, Y.; Tomii, K.; Niho, S.; Nishio, M.; Kato, T.; Takahashi, T.; Ebi, H.; Aono, M.; Yamamoto, N.; Ohe, Y.; Nakagawa, K. Share Save
Rapid Response to Lenvatinib and Disease Flare After Discontinuation in a Patient With Thymic Carcinoma Harboring KIT Exon 11 Mutation: A Case Report Torasawa, Masahiro; Yoshida, Tatsuya; Shiraishi, Kouya; Goto, Naoko; Ueno, Toshihide; Ichikawa, Hitoshi; Yagishita, Shigehiro; Kohsaka, Shinji; Goto, Yasushi; Yatabe, Yasushi; Hamada, Akinobu; Mano, Hiroyuki; Ohe, Yuichiro Share Save
Clinical significance of inter-assay discrepancy in PD-L1 expression evaluation for the efficacy of pembrolizumab in advanced NSCLC patients with high PD-L1 expression Miyakoshi, Jun; Kashima, Jumpei; Shirasawa, Masayuki; Torasawa, Masahiro; Matsumoto, Yuji; Masuda, Ken; Shinno, Yuki; Okuma, Yusuke; Yoshida, Tatsuya; Goto, Yasushi; Horinouchi, Hidehito; Shiraishi, Kouya; Kohno, Takashi; Yamamoto, Noboru; Yatabe, Yasushi; Ohe, Yuichiro Share Save
Diversity of TCR repertoire on peripheral CD8+PD-1+T-cell predicting the PFS of chemoradiotherapy followed by durvalumab maintenance in unresectable locally advanced NSCLC patients Shirasawa, Masayuki; Yoshida, Tatsuya; Takeyasu, Yuki; Matsutani, Takaji; Yagishita, Shigehiro; Kitano, Shigehisa; Kuroda, Hiroaki; Hida, Toyoaki; Kurata, Takayasu; Ohe, Yuichiro Share Save
Advances in cancer DNA methylation analysis with methPLIER: use of non-negative matrix factorization and knowledge-based constraints to enhance biological interpretability Takasawa, Ken; Asada, Ken; Kaneko, Syuzo; Shiraishi, Kouya; Machino, Hidenori; Takahashi, Satoshi; Shinkai, Norio; Kouno, Nobuji; Kobayashi, Kazuma; Komatsu, Masaaki; Mizuno, Takaaki; Okubo, Yu; Mukai, Masami; Yoshida, Tatsuya; Yoshida, Yukihiro; Horinouchi, Hidehito; Watanabe, Shun-Ichi; Ohe, Yuichiro; Yatabe, Yasushi; Kohno, Takashi; Hamamoto, Ryuji Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
